Načítá se...
Variability of Two Metabolomic Platforms in CKD
BACKGROUND AND OBJECTIVES: Nontargeted metabolomics can measure thousands of low-molecular-weight biochemicals, but important gaps limit its utility for biomarker discovery in CKD. These include the need to characterize technical and intraperson analyte variation, to pool data across platforms, and...
Uloženo v:
| Vydáno v: | Clin J Am Soc Nephrol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Nephrology
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6364529/ https://ncbi.nlm.nih.gov/pubmed/30573658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07070618 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|